Glismin PM 2mg/500mg/15mg Tablet SR
Marketer
Phaedrus Life Science Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glismin PM 2mg/500mg/15mg Tablet SR
Diabetic patients may find blood glucose management aided by the combined-action tablet, Glycemia-PM SR (2mg/500mg/15mg). This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. Its mechanism involves enhanced insulin utilization, thus reducing blood sugar. Follow your physician's prescribed dosage and regimen for Glycemia-PM SR; ingestion with food minimizes gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose to compensate. Excessive intake can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other antidiabetic medications, alcohol, or meal skipping elevates hypoglycemia risk; frequent blood glucose monitoring is essential. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, individuals with kidney, liver, or heart conditions, as well as pregnant or breastfeeding women, must consult their doctor. Baseline kidney function tests are typically performed before initiating therapy. Limit alcohol consumption, as it can worsen side effects.
Primary Ingredients of Glismin PM 2mg/500mg/15mg Tablet SR
No information provided. Please provide the text you wish to be rewritten.
Uses of Glismin PM 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glismin PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glismin PM 2mg/500mg/15mg Tablet SR whole; do not alter its form by chewing, crushing, or breaking. Administer this extended-release tablet with a meal.
Common Side effects of Glismin PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glismin PM 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Consume the Glismin PM 2mg/500mg/15mg sustained-release tablet with food.
How Glismin PM 2mg/500mg/15mg Tablet SR works:
Glismin PM 2mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their combined action improves blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further amplifies insulin's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glismin PM 2mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glismin PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glismin PM tablets (2mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Glismin PM 2mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glismin PM 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use the extended-release Glismin PM 2mg/500mg/15mg tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. The Glismin PM 2mg/500mg/15mg extended-release tablet is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glismin PM 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Glismin PM 2mg/500mg/15mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glismin PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently